BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 307069)

  • 1. Platelet-suppressant therapy in patients with coronary artery disease.
    Steele P; Rainwater J; Vogel R; Genton E
    JAMA; 1978 Jul; 240(3):228-31. PubMed ID: 307069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease.
    Steele P; Battock D; Genton E
    Circulation; 1975 Sep; 52(3):473-6. PubMed ID: 1157247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
    Gitler B; Gitler ES
    Am Heart J; 1983 Sep; 106(3):563-70. PubMed ID: 6410893
    [No Abstract]   [Full Text] [Related]  

  • 4. Status of antiplatelet drugs in coronary heart disease.
    Mehta J; Mehta P
    JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiplatelet therapy.
    Turpie AG
    Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of drugs of platelets and complications of vascular disease.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet suppressant therapy in patients with prosthetic cardiac valves. Relationship of clinical effectiveness to alteration of platelet survival time.
    Steele P; Rainwater J; Vogel R
    Circulation; 1979 Oct; 60(4):910-3. PubMed ID: 476893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of platelet survival time with occlusion of saphenous vein aorto-coronary bypass grafts.
    Steele P; Battock D; Pappas G; Genton E
    Circulation; 1976 Apr; 53(4):685-7. PubMed ID: 1082802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
    Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Comparative effects of platelet suppressant drugs on platelet survival time.
    Genton E; Ellis J; Steele P
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198422
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
    Cairns JA
    Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983
    [No Abstract]   [Full Text] [Related]  

  • 14. Are agents affecting platelet function clinically useful in patients with coronary artery disease?
    Verstraete M
    Acta Clin Belg; 1976; 31(4):229-32. PubMed ID: 1087523
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.
    Verstraete M; Brown BG; Chesebro JH; Ekeström S; Harker LA; Henderson AH; Jewitt DE; Oliver MF; Sleight P
    Eur Heart J; 1986 Jan; 7(1):4-13. PubMed ID: 3514223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiplatelet drugs (author's transl)].
    Dechavanne M; Follea G; Trzeciak MC
    Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
    Chesebro JH; Fuster V; Elveback LR; Clements IP; Smith HC; Holmes DR; Bardsley WT; Pluth JR; Wallace RB; Puga FJ
    N Engl J Med; 1984 Jan; 310(4):209-14. PubMed ID: 6361561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of anticoagulant management after coronary artery bypass surgery--warfarin versus dipyridamole].
    Yamaguchi A; Kitamura N; Miki T; Tatebayashi T; Kawashima M; Otaki M; Tamura H
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Apr; 40(4):485-9. PubMed ID: 1613273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.